Nishigaki Kazuo, Hanson Charlotte, Ohashi Takashi, Spadaccini Angelo, Ruscetti Sandra
Laboratory of Cancer Prevention, National Cancer Institute-Frederick, Frederick, MD 21702-1201, USA.
J Virol. 2006 Jun;80(12):5678-85. doi: 10.1128/JVI.02651-05.
Infection of mice with Friend spleen focus-forming virus (SFFV) results in a multistage erythroleukemia. In the first stage, the SFFV envelope glycoprotein interacts with the erythropoietin receptor and a short form of the receptor tyrosine kinase sf-Stk, resulting in constitutive activation of signal transducing molecules and the development of erythropoietin (Epo)-independent erythroid hyperplasia and polycythemia. The second stage results from the outgrowth of a rare virus-infected erythroid cell that expresses nonphysiological levels of the myeloid transcription factor PU.1. These cells exhibit a differentiation block and can be grown as murine erythroleukemia (MEL) cell lines. In this study, we examined SFFV MEL cells to determine whether their transformed phenotype was associated with a block in the activation of any Epo signal-transducing molecules. Our studies indicate that Epo- or SFFV-induced activation of STAT1/3 DNA binding activity is blocked in SFFV MEL cells. The block is at the level of tyrosine phosphorylation of STAT1, although Jak2 phosphorylation is not blocked in these cells. In contrast to Epo, alpha interferon can induce STAT1 phosphorylation and DNA binding in SFFV MEL cells. The SFFV-transformed cells were shown to express elevated levels of the hematopoietic phosphatase SHP-1, and treatment of the cells with a phosphatase inhibitor restored STAT1 tyrosine phosphorylation. MEL cells derived from Friend murine leukemia virus (MuLV) or ME26 MuLV-infected mice, which do not express PU.1, express lower levels of SHP-1 and are not blocked in STAT1/3 DNA-binding activity. Our studies suggest that SFFV-infected erythroid cells become transformed when differentiation signals activated by STAT1/3 are blocked due to high SHP-1 levels induced by inappropriate expression of the PU.1 protein.
用弗瑞德脾集落形成病毒(SFFV)感染小鼠会导致多阶段的红细胞白血病。在第一阶段,SFFV包膜糖蛋白与促红细胞生成素受体以及受体酪氨酸激酶sf-Stk的一种短形式相互作用,导致信号转导分子的组成性激活以及促红细胞生成素(Epo)非依赖性红细胞增生和红细胞增多症的发展。第二阶段源于一种罕见的病毒感染红细胞的增殖,这种细胞表达非生理性水平的髓系转录因子PU.1。这些细胞表现出分化阻滞,并且可以作为小鼠红细胞白血病(MEL)细胞系生长。在本研究中,我们检测了SFFV MEL细胞,以确定它们的转化表型是否与任何Epo信号转导分子激活的阻滞有关。我们的研究表明,在SFFV MEL细胞中,Epo或SFFV诱导的STAT1/3 DNA结合活性的激活被阻断。这种阻滞发生在STAT1的酪氨酸磷酸化水平,尽管在这些细胞中Jak2磷酸化未被阻断。与Epo相反,α干扰素可以在SFFV MEL细胞中诱导STAT1磷酸化和DNA结合。SFFV转化细胞显示出造血磷酸酶SHP-1的表达水平升高,用磷酸酶抑制剂处理这些细胞可恢复STAT1酪氨酸磷酸化。源自弗瑞德鼠白血病病毒(MuLV)或ME26 MuLV感染小鼠且不表达PU.1的MEL细胞,SHP-1表达水平较低,并且STAT1/3 DNA结合活性未被阻断。我们的研究表明,当由于PU.1蛋白的不适当表达诱导的高SHP-1水平导致STAT1/3激活的分化信号被阻断时,SFFV感染的红细胞会发生转化。